Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.
暂无分享，去创建一个
R. Dummer | B. Dréno | S. Eichmüller | O. Dereure | M. Lusky | T. Waterboer | C. Assaf | M. Bagot | A. Khammari | M. Schiller | S. Gellrich | B. Acres | M. Urosevic-Maiwald | P. Bleuzen | V. Bataille | M. Baudard | N. Wiedemann | Anna Derbij